Theranostics

265.7k citations
5.0k papers · · active since 1950

Impact in

    • MicroRNA in disease regulation
    • Cancer-related molecular mechanisms research
    • Nanoparticle-Based Drug Delivery

Papers in

    • MicroRNA in disease regulation 302
    • Cancer-related molecular mechanisms research 208
    • Nanoparticle-Based Drug Delivery 392

Theranostics

4.7k papers receiving 260.9k citations

Peers

Theranostics
Comparison fields: 5 of 221
  • Cancer Research 40.2k
  • Biomaterials 34.0k
  • Biomedical Engineering 73.7k
  • Molecular Biology 108.5k
  • Immunology 24.4k
Replace Nature Reviews Drug Discovery with:
Nature Reviews Drug Discovery United States
Biochimica et Biophysica Acta (BBA) - General Subjects United States
Biomedicine & Pharmacotherapy China
Frontiers in Pharmacology China
Molecular Pharmaceutics United States
International Journal of Nanomedicine China
Pharmaceutical Research United States
Biochimica et Biophysica Acta (BBA) - Biomembranes United States
Drug Discovery Today United States
Science Translational Medicine United States
Theranostics relative to Nature Reviews Drug Discovery United States Nature Reviews Drug Discovery's profile →
Citations per field
00.5×1.5×
Nature Reviews Drug Discovery · 1×
Citations per year

Countries where authors publish in Theranostics

Since Specialization
Citations

This map shows the geographic impact of research published in Theranostics. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers published in Theranostics with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Theranostics more than expected).

Fields of papers published in Theranostics

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers published in Theranostics. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers published in Theranostics.

About Theranostics

The 5.0k papers published in Theranostics in the last decades have received a total of 265.7k indexed citations . Papers published in Theranostics usually cover Cancer Research (772 papers), Biomaterials (492 papers), Immunology (682 papers), Molecular Biology (2.3k papers) and Oncology (821 papers) specifically the topics of Nanoplatforms for cancer theranostics (728 papers), Nanoparticle-Based Drug Delivery (392 papers), Extracellular vesicles in disease (329 papers), MicroRNA in disease regulation (302 papers), RNA Interference and Gene Delivery (302 papers), Advanced biosensing and bioanalysis techniques (250 papers), RNA modifications and cancer (221 papers) and Cancer-related molecular mechanisms research (208 papers). The most active scholars publishing in Theranostics are Xiaowei Dong, Peng Mi, Irina Velikyan, Zhiqiang Gao, Hisataka Kobayashi, Peter L. Choyke, Jiang Xia, Yujie Liang, Pin Li and Sze Han Lee.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore journals with similar magnitude of impact